Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia (Q66043311)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia |
clinical trial |
Statements
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Doses and Dose Regimens of Evinacumab in Patients With Persistent Hypercholesterolemia Despite Maximally Tolerated Lipid Modifying Therapy (English)
0 references
10 November 2017
0 references
6 April 2020
0 references
252
0 references
18 year
0 references
80 year
0 references